Showing results (181-190 of 287) with videos related to
Sort By:
Pageof 29
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2018
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trialEdward J Fox, Clyde Markowitz, Angela Applebee, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1997
Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosisS A Brod, R H Kerman, L D Nelson, et al.Clinical Trials (London, England)|April 2, 2014
Recruitment of participants to a multiple sclerosis trial: the CombiRx experienceMinal J Bhanushali, Tarah Gustafson, Steve Powell, et al.European Journal of Neurology|April 29, 2006
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosisM Filippi, M A Rocca, D L Arnold, et al.Neurology|May 10, 2000
Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide InvestigatorsJ S Wolinsky, P A Narayana, J H Noseworthy, et al.Neurology|August 19, 2009
The challenge of follow-on biologics for treatment of multiple sclerosisS C Reingold, J P Steiner, C H Polman, et al.Journal of Clinical Neuro-Ophthalmology|December 1, 1983
Downbeat nystagmus. A case report of herpetic brain stem encephalitisL W Hirst, A W Clark, J S Wolinsky, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2017
Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data setMarcus W Koch, Gary R Cutter, Gavin Giovannoni, et al.Journal of Neuroimmunology|November 26, 2018
Exploring the relationship between Endothelin-1 and peripheral inflammation in multiple sclerosisNatalia P Rocha, Gabriela D Colpo, Javiera Bravo-Alegria, et al.Annals of Neurology|January 31, 2007
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trialJerry S Wolinsky, Ponnada A Narayana, Paul O'Connor, et al.Pageof 29